Home › Arthritis › NCT02418442
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
RecruitingObservational study
Who can join
Up to age 21 · All sexes
Full eligibility criteria
Inclusion Criteria: 1. Onset of rheumatic disease prior to age 16 years for JIA and onset prior to age 19 years for all other rheumatic diseases (see appendix A). 2. Subject (and/or parent/legal guardian when required) is able to provide written informed consent and willing to comply with study procedures. 3. Subject and/or parent/legal guardian is willing to be contacted in the future by study staff. Exclusion Criteria: 1\. Greater than 21 years of age at the time of enrollment.
About the study
Continuation of the CARRA Registry as described in the protocol will support data collection on patients with pediatric-onset rheumatic diseases. The CARRA Registry will form the basis for future CARRA studies. In particular, this observational registry will be used to answer pressing questions about therapeutics used to treat pediatric rheumatic diseases, including safety questions.
Sponsor: Duke University · Participants: 20,000 · Started: 2015-07
Contact the study team
- Mara L Becker, MD, MSCE · Phone: (919) 419-5032
- Mary Beth Son, MD · Phone: (617) 919-6083
Official record on ClinicalTrials.gov — NCT02418442
Locations in the U.S.
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.